ACLU
US Senate Hearings Consider Bipartisan Proposal to Change Patent Laws; Could Have Big Impact on Dx
A draft bill provides for a major expansion of eligible material, a move the ACLU and AMP said threatens to reduce competition in genetic testing.
Down to the Interpretation
Mother Jones reports that some data used for interpreting what BRCA1 or BRCA2 mutations mean are kept private.
Experts Debate MDx Industry Impact of AMP v. Myriad Three Years After Court's Decision
The US Supreme Court decision cleared the way for large-scale sequencing or drove prices to unsustainable levels, depending on your opinion.
Hidden Away
A cancer patient with a rare BRCA1 variant seeks better data sharing, Newsweek reports.
Patients File HIPAA Complaint Against Myriad Genetics for Withholding Variant Data
Four patients still want the government to investigate their allegations against Myriad, even though the firm complied with their data request at the last hour.
Oct 13, 2011
Sep 7, 2011
Apr 5, 2011
Myriad, ACLU Case Hits Higher Court
Jun 30, 2010
Jun 23, 2010
Jun 16, 2010